Cargando…
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
BACKGROUND: Opioid dependence carries the highest disease burden of all illicit drugs. Opioid agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity and mortality. There is limited knowledge on the health-related quality of life (HRQoL) of long-term patients in OAT. T...
Autores principales: | Aas, Christer Frode, Vold, Jørn Henrik, Skurtveit, Svetlana, Lim, Aaron G., Ruths, Sabine, Islam, Kamrul, Askildsen, Jan Erik, Løberg, Else-Marie, Fadnes, Lars Thore, Johansson, Kjell Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469909/ https://www.ncbi.nlm.nih.gov/pubmed/32883319 http://dx.doi.org/10.1186/s13011-020-00309-y |
Ejemplares similares
-
Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020) -
Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020) -
Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022) -
Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020) -
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
por: Aas, Christer Frode, et al.
Publicado: (2021)